181 related articles for article (PubMed ID: 11720864)
1. Biological activity in human neutrophils of di-tripeptides, analogues of the chemotactic fMLP.
Cavicchioni G; Turchetti M; Spisani S
Bioorg Med Chem Lett; 2001 Dec; 11(24):3157-9. PubMed ID: 11720864
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of fMLP pocket dimensions and features using formyltetrapeptides.
Cavicchioni G; Varani K; Niccoli S; Rizzuti O; Spisani S
J Pept Res; 1999 Oct; 54(4):336-43. PubMed ID: 10532239
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship of for-L-Met L-Leu-L-Phe-OMe analogues in human neutrophils.
Cavicchioni G; Fraulini A; Falzarano S; Spisani S
Bioorg Chem; 2006 Oct; 34(5):298-318. PubMed ID: 16919307
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological activity and conformational studies of geometrically restricted tripeptide analogues of the chemoattractant HCO-Met-Leu-Phe-OMe.
Boggian M; Vertuani G; Cavicchioni G; Pecoraro R; Scatturin A; Spisani S
Farmaco; 1997; 52(6-7):439-44. PubMed ID: 9372595
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological activity, conformational analysis by NMR and molecular modeling of N-formyl-L-Met-L-Pro-L-Phe-OMe, a proline analogue of the chemotactic peptide N-formyl-L-Met-L-Leu-L-Phe-OH.
Dugas H; Laroche M; Ptak M; Labbé H
Int J Pept Protein Res; 1993 Jun; 41(6):595-605. PubMed ID: 8394292
[TBL] [Abstract][Full Text] [Related]
6. Biological variation responses in fMLP-OMe analogs, introducing bulky protecting groups on the side-chain of hydrophilic residues at position 2.
Cavicchioni G; Turchetti M; Spisani S
J Pept Res; 2002 Oct; 60(4):223-31. PubMed ID: 12366529
[TBL] [Abstract][Full Text] [Related]
7. Hybrid alpha/beta3-peptides with proteinogenic side chains. Monosubstituted analogues of the chemotactic tripeptide For-Met-Leu-Phe-OMe.
Giordano C; Lucente G; Mollica A; Nalli M; Pagani Zecchini G; Paglialunga Paradisi M; Gavuzzo E; Mazza F; Spisani S
J Pept Sci; 2004 Aug; 10(8):510-23. PubMed ID: 15347138
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, conformation, and biological activity of two fMLP-OMe analogues containing the new 2-[2'-(methylthio)ethyl]methionine residue.
Torrini I; Paglialunga Paradisi M; Pagani Zecchini G; Lucente G; Gavuzzo E; Mazza F; Pochetti G; Traniello S; Spisani S
Biopolymers; 1997 Oct; 42(4):415-26. PubMed ID: 9283291
[TBL] [Abstract][Full Text] [Related]
9. New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor.
Spisani S; Fraulini A; Varani K; Falzarano S; Cavicchioni G
Eur J Pharmacol; 2007 Jul; 567(1-2):171-6. PubMed ID: 17481605
[TBL] [Abstract][Full Text] [Related]
10. Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues.
Ferretti ME; Nalli M; Biondi C; Colamussi ML; Pavan B; Traniello S; Spisani S
Cell Signal; 2001 Apr; 13(4):233-40. PubMed ID: 11306240
[TBL] [Abstract][Full Text] [Related]
11. fMLP-OMe analogs substituted at the methionine residue: an insight into the receptor properties.
Cavicchioni G; Monesi LG; Ferretti ME; Fabbri E; Rizzuti O; Spisani S
Arch Pharm (Weinheim); 1998 Nov; 331(11):368-70. PubMed ID: 9881061
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and chemotactic activity of the fMLP analog HCO-Hmb-Leu-Phe-OMe.
Zecchini GP; Paradisi MP; Torrini I; Lucente G; Traniello S; Spisani S
Arch Pharm (Weinheim); 1993 Aug; 326(8):461-5. PubMed ID: 8215843
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and activity on human neutrophil functions of fMLF-OMe analogs containing alkyl spacers at the central position.
Pagani Zecchini G; Morera E; Nalli M; Paglialunga Paradisi M; Lucente G; Spisani S
Farmaco; 2001 Nov; 56(11):851-8. PubMed ID: 11765037
[TBL] [Abstract][Full Text] [Related]
14. Modified chemotactic peptides: synthesis and biological activity of HCO-Met-delta ZLeu-delta ZPhe-OMe.
Pagani Zecchini G; Torrini I; Paglialunga Paradisi M; Lucente G; Spisani S
Farmaco; 1994 Nov; 40(11):739-42. PubMed ID: 7832975
[TBL] [Abstract][Full Text] [Related]
15. A hydrophilic residue at position 2 can improve specific biological responses in fMLP-OMe analogs.
Cavicchioni G; Spisani S
J Pept Res; 2001 Sep; 58(3):257-62. PubMed ID: 11576332
[TBL] [Abstract][Full Text] [Related]
16. Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs.
Pagani Zecchini G; Nalli M; Mollica A; Lucente G; Paglialunga Paradisi M; Spisani S
J Pept Res; 2002 Jun; 59(6):283-91. PubMed ID: 12010519
[TBL] [Abstract][Full Text] [Related]
17. Pseudopeptides containing the 2-hydrazonoacyl fragment: analogs of the chemotactic agent HCO-Met-Leu-Phe-OMe.
Torrini I; Nalli M; Paglialunga Paradisi M; Pagani Zecchini G; Lucente G; Spisani S
J Pept Res; 2001 Jul; 58(1):56-66. PubMed ID: 11454170
[TBL] [Abstract][Full Text] [Related]
18. Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils.
Cavicchioni G; Fraulini A; Turchetti M; Varani K; Falzarano S; Pavan B; Spisani S
Eur J Pharmacol; 2005 Apr; 512(1):1-8. PubMed ID: 15814083
[TBL] [Abstract][Full Text] [Related]
19. Chemotactic peptide analogues. Centrally constrained chemotactic N-formyltripeptides: synthesis, conformation, and activity of two new analogues.
Pagani Zecchini G; Paglialunga Paradisi M; Torrini I; Lucente G; Mastropietro G; Paci M; Spisani S
Arch Pharm (Weinheim); 1996 Dec; 329(12):517-23. PubMed ID: 9038418
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of new active For-Met-Leu-Phe-OMe analogues containing para-substituted Phe residues.
Mollica A; Feliciani F; Stefanucci A; Costante R; Lucente G; Pinnen F; Notaristefano D; Spisani S
J Pept Sci; 2012 Jun; 18(6):418-26. PubMed ID: 22528501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
